Companies can prepare for a Chinese drug quality audit by ensuring compliance with China’s Good Manufacturing Practices (GMP), conducting internal audits, maintaining detailed documentation, training staff on regulatory requirements, and implementing robust quality control systems. Engaging local regulatory experts and staying updated on Chinese regulations can further enhance readiness and compliance.
